Midatech Pharma plc
MTP · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -2,612% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -2,755.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -4,230.1% |
| EPS Diluted | -15.06 | -3.65 | -7.92 | -1.13 |
| % Growth | -312.6% | 53.9% | -600.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |